Decreased expression of ARID1A associates with poor prognosis and promotes metastases of hepatocellular carcinoma

Abstract

ARID1A served as an important tumor suppressor. Decreased expression of ARID1A was associated with tumor progression, metastasis, and reduced overall survival in mice and humans. ARID1A could represent a promising candidate therapeutic target for HCC.